Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
USA v. Tanner et al
Case Number:
1:17-cr-00061
Court:
Nature of Suit:
Firms
-
April 10, 2020
Jailed Pharma Exec Claiming COVID-19 Risk Denied Release
A New York federal judge rejected a health-related home confinement request by the imprisoned ex-CEO of defunct pharmacy Philidor Rx Services LLC, finding Thursday that the Pennsylvania prison where he is serving time for a $9.7 million kickback scheme has no known cases of COVID-19.
-
March 23, 2020
Ex-Pharma Exec Seeks Early Prison Exit Over COVID-19 Risk
The former CEO of defunct pharmacy Philidor Rx Services LLC who was convicted in a $9.7 million kickback scheme tied to a potential acquisition deal has asked a New York federal judge to allow him to serve the remainder of his prison term in home confinement, citing the risk of exposure to the novel coronavirus.
-
January 30, 2019
Pharma Fraudsters To Pay Valeant $11.8M Over Kickback Plot
Already sentenced to forfeit nearly $10 million apiece, a former Valeant Pharmaceuticals International Inc. executive and the ex-CEO of a mail-order pharmacy were ordered by a New York federal judge on Wednesday to pay Valeant more than $11.8 million in restitution for their $9.7 million kickback scheme.
-
January 01, 2019
White Collar Cases To Watch In 2019
The coming year's white collar docket is an active one, with several large health care fraud cases set to go to trial and post-trial litigation that could shape the law in insider trading and other financial crimes and affect how companies cooperate in criminal probes.
-
October 30, 2018
Ex-Valeant Exec, Pharmacy CEO Get Year For Kickback Fraud
A former Valeant Pharmaceuticals International Inc. executive and the ex-CEO of mail-order pharmacy Philidor Rx Services LLC were each sentenced Tuesday to a year and a day in prison for orchestrating a $9.7 million kickback scheme tied to a potential acquisition deal.
-
July 18, 2018
No New Trial For 2 Convicted In Valeant Fraud
A New York federal judge rejected a request for a new trial for two men accused of defrauding Valeant Pharmaceuticals International Inc., saying at a Wednesday hearing that their concerns about a juror didn't rise to the level that a do-over was required.
-
June 20, 2018
Feds Fight Convicted Ex-Valeant Exec's Claims Of Juror Bias
Prosecutors told a New York federal court Tuesday that a former Valeant Pharmaceuticals International Inc. manager's conviction over a $9.7 million kickback plot can't be scrapped just because one of the jurors in the case didn't disclose that she was involved in a civil lawsuit, saying the exec's motion for a new trial should be denied.
-
June 06, 2018
Convicted Valeant Exec Says Dishonest Juror Tainted Trial
A former Valeant Pharmaceuticals International Inc. manager awaiting sentencing for his role in a $9.7 million kickback plot has urged a Manhattan federal judge to scrap his conviction, saying one of the jurors lied to hide that she's embroiled in a lawsuit alleging she abused disabled adults at a care facility.
-
May 22, 2018
Ex-Manager, CEO Convicted In $9.7M Valeant Kickback Plot
A former manager at Valeant Pharmaceuticals International Inc. and the CEO of a mail-order pharmacy whose close ties to the drugmaker led to a federal investigation were convicted by a Manhattan federal jury on Tuesday of scheming to bring about a tie-up between the companies in exchange for a $9.7 million kickback.
-
May 17, 2018
$9.7M Valeant Payment Was Legal, Ex-Execs Argue In Closing
Prosecutors and two health care businessmen charged with defrauding Valeant Pharmaceuticals International Inc. out of $9.7 million when it moved to buy mail-order pharmacy Philidor Rx Services LLC made their closing arguments to a Manhattan federal jury on Thursday, advancing competing views of whether Valeant was a victim or a beneficiary of Philidor's rise.